The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of chemotherapy plus pembrolizumab in patients with advanced NSCLC previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029.
 
Nikhil Shukla
Patents, Royalties, Other Intellectual Property - Combination of SapC-DOPS and AS1411 for the treatment of glioblastoma multiforme (Inst)
 
Sandra K. Althouse
No Relationships to Disclose
 
Susan Perkins
No Relationships to Disclose
 
Muhammad Furqan
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; BeiGene; Jazz Pharmaceuticals
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Biothera (Inst); Celgene (Inst); Genentech (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Ticiana Leal
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; BeyondSpring Pharmaceuticals; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Debiopharm Group; EMD Serono; Genentech; Genentech; InvisionFirst Lung; Jazz Pharmaceuticals; Lilly; Merck; Merck; Merck; Novocure; Takeda
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck; Mirati Therapeutics; Mirati Therapeutics; Mirati Therapeutics; Takeda; Takeda
(OPTIONAL) Uncompensated Relationships - Mirati Therapeutics
 
Nasser H. Hanna
Honoraria - UpToDate
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck KGaA (Inst)
Other Relationship - BeyondSpring Pharmaceuticals; BeyondSpring Pharmaceuticals
 
Greg Andrew Durm
Honoraria - AstraZeneca; Curio Science
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)